This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
acute respiratory | 656 |
respiratory syndrome | 622 |
severe acute | 605 |
hong kong | 336 |
imaging findings | 188 |
sars coronavirus | 168 |
public health | 161 |
avian influenza | 147 |
binding site | 137 |
united states | 127 |
amino acid | 126 |
converting enzyme | 125 |
binding sites | 124 |
cord uid | 121 |
doc id | 121 |
mr imaging | 110 |
learning objectives | 109 |
influenza virus | 102 |
health care | 101 |
sars patients | 99 |
world health | 94 |
cognitive impairment | 90 |
infectious diseases | 88 |
amino acids | 87 |
health organization | 86 |
spike protein | 86 |
class i | 83 |
differential diagnosis | 80 |
novel coronavirus | 78 |
respiratory tract | 76 |
infection control | 75 |
magnetic resonance | 73 |
associated coronavirus | 72 |
nervous system | 72 |
procedure details | 71 |
influenza viruses | 71 |
immune response | 69 |
health behaviors | 68 |
infectious disease | 66 |
west nile | 66 |
central nervous | 65 |
sars outbreak | 65 |
rpe cells | 64 |
serum samples | 63 |
nile virus | 63 |
hepatitis virus | 62 |
infected cells | 61 |
sars virus | 60 |
class ii | 59 |
virus infection | 59 |
chain reaction | 59 |
human metapneumovirus | 59 |
multiple sclerosis | 57 |
rotavirus infection | 57 |
polymerase chain | 57 |
ctl escape | 56 |
infectious bronchitis | 56 |
membrane proteins | 55 |
white matter | 55 |
computed tomography | 55 |
mouse hepatitis | 55 |
rna viruses | 55 |
contrast enhancement | 54 |
spiral ct | 54 |
epithelial cells | 53 |
nucleocapsid protein | 52 |
risk factors | 51 |
respiratory syncytial | 51 |
escape mutants | 51 |
plasma membrane | 51 |
electron microscopy | 50 |
mhc class | 50 |
significant difference | 50 |
infectious agents | 49 |
virus particles | 49 |
control measures | 49 |
syncytial virus | 48 |
membrane protein | 48 |
bronchitis virus | 48 |
crystal structure | 48 |
may also | 48 |
blood flow | 48 |
lipid bilayer | 48 |
signal intensity | 47 |
protein structures | 47 |
care workers | 46 |
transmembrane domain | 45 |
performed using | 45 |
breast cancer | 45 |
matrix protein | 45 |
soft tissue | 45 |
coronavirus associated | 45 |
coronavirus infection | 45 |
homology models | 45 |
patients underwent | 45 |
image quality | 44 |
one patient | 44 |
viral load | 44 |
mean age | 42 |
syndrome coronavirus | 42 |
poly i | 42 |
reverse transcription | 42 |
western blot | 41 |
spinal cord | 41 |
structural proteins | 41 |
clinical features | 41 |
vero cells | 41 |
probable sars | 41 |
influenza pandemic | 41 |
jp purpose | 40 |
enveloped viruses | 40 |
cell culture | 39 |
sars cov | 39 |
electricity market | 39 |
endoplasmic reticulum | 39 |
pandemic influenza | 39 |
infected patients | 39 |
ct findings | 39 |
emerging infectious | 38 |
disease control | 38 |
row ct | 38 |
present study | 38 |
dendritic cells | 38 |
statistically significant | 37 |
cell lines | 37 |
small bowel | 37 |
virus type | 37 |
intensive care | 37 |
cov infection | 37 |
prospective study | 36 |
membrane fusion | 36 |
coronavirus spike | 36 |
active site | 36 |
protein structure | 35 |
respiratory distress | 35 |
transplanted animals | 35 |
immune responses | 35 |
immunodeficiency virus | 34 |
highly pathogenic | 34 |
respiratory illness | 34 |
significantly higher | 34 |
term infants | 34 |
important role | 34 |
murine coronavirus | 34 |
critically ill | 34 |
lung cancer | 34 |
cell surface | 33 |
distress syndrome | 33 |
healthcare workers | 33 |
two patients | 33 |
lymph nodes | 33 |
imaging modalities | 32 |
weighted images | 32 |
global health | 32 |
resonance imaging | 32 |
cell line | 32 |
angiotensin i | 32 |
mr images | 32 |
human immunodeficiency | 32 |
complete protein | 32 |
room temperature | 32 |
helical ct | 32 |
ebola virus | 31 |
rural electricity | 31 |
mg ml | 31 |
viral rna | 31 |
respiratory viruses | 31 |
high resolution | 31 |
sequence identity | 31 |
imaging features | 31 |
contrast enhanced | 31 |
viral proteins | 31 |
encephalitis virus | 31 |
infected mice | 31 |
one case | 30 |
liquid crystalline | 30 |
symptom onset | 30 |
sars epidemic | 30 |
lymph node | 30 |
ct angiography | 30 |
viral infection | 30 |
escherichia coli | 29 |
ts mutant | 29 |
spike glycoprotein | 29 |
blood pressure | 29 |
bone marrow | 29 |
electricity demand | 29 |
wide range | 29 |
genome sequence | 29 |
animal models | 29 |
monoclonal antibodies | 29 |
caprylic acid | 29 |
specific antibodies | 29 |
contrast agent | 28 |
gene expression | 28 |
infect dis | 28 |
endothelial cells | 28 |
cells within | 28 |
virus inactivation | 28 |
venezuelan equine | 28 |
study group | 28 |
equine encephalitis | 28 |
neutralizing antibodies | 28 |
ct scans | 28 |
immune system | 28 |
young children | 27 |
ii mhc | 27 |
southern china | 27 |
ts mutants | 27 |
sars cases | 27 |
neutralizing antibody | 27 |
mhv infection | 27 |
protease inhibitors | 27 |
pictorial review | 27 |
antibody responses | 27 |
sars clpro | 27 |
will also | 27 |
fatty acyl | 27 |
virus vaccine | 27 |
diagnostic accuracy | 27 |
preventive behaviors | 27 |
slice thickness | 26 |
hydrophobic thickness | 26 |
exhaust air | 26 |
like particles | 26 |
convalescent sera | 26 |
drug design | 26 |
effective reproduction | 26 |
air purifier | 26 |
nucleic acid | 26 |
total number | 26 |
antiphospholipid syndrome | 26 |
ct images | 26 |
pcr assays | 26 |
glial cells | 26 |
lower respiratory | 26 |
viral safety | 26 |
contrast agents | 26 |
matrix proteins | 26 |
fatty acid | 26 |
closely related | 26 |
reverse transcriptase | 26 |
sequence analysis | 25 |
antibody response | 25 |
upper respiratory | 25 |
uk learning | 25 |
east asian | 25 |
type i | 25 |
cerebral blood | 25 |
ang ii | 25 |
cleavage site | 25 |
reverse genetics | 25 |
commercially available | 25 |
heart failure | 25 |
atomic force | 25 |
human igg | 25 |
two groups | 25 |
significant differences | 25 |
mice infected | 25 |
tract infections | 25 |
drug discovery | 25 |
wishful thinking | 25 |
emerging markets | 25 |
binding protein | 25 |
human influenza | 24 |
mortality rate | 24 |
light system | 24 |
transmissible gastroenteritis | 24 |
ct scan | 24 |
viral replication | 24 |
respiratory disease | 24 |
large number | 24 |
guangdong province | 24 |
wide spectrum | 24 |
probable cases | 24 |
chronic hepatitis | 24 |
empathic responding | 24 |
human beings | 24 |
predictive value | 24 |
vesicular stomatitis | 24 |
sindbis virus | 24 |
task force | 24 |
epidemic curves | 23 |
data set | 23 |
crystal structures | 23 |
human transmission | 23 |
reproduction numbers | 23 |
stomatitis virus | 23 |
blood donors | 23 |
main proteinase | 23 |
asian nies | 23 |
per year | 23 |
retrospectively reviewed | 23 |
molecular dynamics | 23 |
three times | 23 |
clinical presentation | 23 |
within days | 23 |
close contact | 23 |
support seeking | 23 |
human disease | 23 |
acquired pneumonia | 23 |
infectious virus | 22 |
transmembrane ot | 22 |
new york | 22 |
coronary artery | 22 |
cystic lesions | 22 |
acid sequence | 22 |
lung tissue | 22 |
virtual screening | 22 |
pcr products | 22 |
nonpermissive temperature | 22 |
coronavirus main | 22 |
core biopsy | 22 |
pathogenic avian | 22 |
least one | 22 |
type ii | 22 |
human plasma | 22 |
major histocompatibility | 22 |
influenza vaccines | 22 |
chest radiographs | 22 |
ranking solutions | 22 |
real time | 22 |
respiratory failure | 22 |
contrast medium | 22 |
antigen expression | 22 |
influenza vaccine | 22 |
significantly lower | 22 |
dis doi | 21 |
clinical manifestations | 21 |
inflammatory response | 21 |
spike polypeptide | 21 |
determine whether | 21 |
clinical symptoms | 21 |
molecular biology | 21 |
clinical course | 21 |
linked immunosorbent | 21 |
year period | 21 |
chest radiograph | 21 |
two cases | 21 |
syndrome virus | 21 |
viral particles | 21 |
mm tris | 21 |
heart disease | 21 |
golgi complex | 21 |
case definition | 21 |
acyl chains | 21 |
aortic dissection | 21 |
volume rendering | 21 |
growth rate | 21 |
united kingdom | 21 |
cell response | 21 |
developing countries | 21 |
inflammatory responses | 21 |
ill patients | 21 |
dengue virus | 21 |
health belief | 21 |
urinary tract | 21 |
gastrointestinal tract | 21 |
narrow bandwidth | 21 |
rotavirus infections | 21 |
belief model | 21 |
histocompatibility complex | 21 |
carotid artery | 21 |
results obtained | 20 |
surgical treatment | 20 |
human coronavirus | 20 |
asian tigers | 20 |
data suggest | 20 |
early diagnosis | 20 |
bovine coronavirus | 20 |
intensity projection | 20 |
respiratory symptoms | 20 |
immunosorbent assay | 20 |
bandwidth light | 20 |
genbank accession | 20 |
mm nacl | 20 |
cell types | 20 |
pcr assay | 20 |
previous studies | 20 |
four patients | 20 |
immunofluorescence assay | 20 |
north america | 20 |
acid residues | 20 |
infectious agent | 20 |
three different | 20 |
peripheral blood | 20 |
growth rates | 20 |
virus infections | 20 |
care unit | 19 |
coronary angiography | 19 |
healthy blood | 19 |
south korea | 19 |
scanning electron | 19 |
homology modeling | 19 |
cells expressing | 19 |
viral infections | 19 |
maximum intensity | 19 |
avian infectious | 19 |
human infection | 19 |
hydrophobic length | 19 |
age group | 19 |
homology model | 19 |
rna polymerase | 19 |
recombinant nucleocapsid | 19 |
imaging modality | 19 |
ct scanner | 19 |
gr purpose | 19 |
contrast material | 19 |
reproduction number | 19 |
myocardial infarction | 19 |
cell cultures | 19 |
also found | 19 |
vaccine development | 19 |
rna virus | 19 |
nested pcr | 19 |
age range | 19 |
mhc expression | 19 |
severe respiratory | 19 |
wide variety | 19 |
blot assays | 19 |
monoclonal antibody | 19 |
virus replication | 19 |
ct imaging | 18 |
pleural effusion | 18 |
cell epitopes | 18 |
vaccinia virus | 18 |
main protease | 18 |
control subjects | 18 |
based elisa | 18 |
insect ace | 18 |
map testing | 18 |
integrated air | 18 |
elisa kit | 18 |
substrate specificity | 18 |
host cell | 18 |
neutral endopeptidase | 18 |
direct contact | 18 |
possible cause | 18 |
patients treated | 18 |
generation interval | 18 |
mmol kg | 18 |
canine coronavirus | 18 |
icu survivors | 18 |
clinical disease | 18 |
university hospital | 18 |
incubation period | 18 |
angiotensin converting | 18 |
virtual endoscopy | 18 |
retinal pigment | 18 |
liver fah | 18 |
economic development | 18 |
giant panda | 18 |
chest wall | 18 |
genetic groups | 18 |
clinical trials | 18 |
emerg infect | 18 |
ray crystal | 18 |
dans le | 18 |
consecutive patients | 18 |
infectious diarrhea | 18 |
clinical signs | 18 |
cell fusion | 18 |
disease progression | 18 |
three patients | 18 |
human cases | 17 |
atypical pneumonia | 17 |
time pcr | 17 |
sg cells | 17 |
rabbit anti | 17 |
sars case | 17 |
nosocomial transmission | 17 |
statistical analysis | 17 |
cytopathic effect | 17 |
parainfluenza virus | 17 |
study population | 17 |
widely used | 17 |
mm slice | 17 |
protein kinase | 17 |
retrospective analysis | 17 |
porcine reproductive | 17 |
color doppler | 17 |
indirect immunofluorescence | 17 |
necrotizing enterocolitis | 17 |
spin echo | 17 |
human rights | 17 |
dans les | 17 |
flow volume | 17 |
limited number | 17 |
stem cell | 17 |
small number | 17 |
functional receptor | 17 |
secondary cases | 17 |
antibody titer | 17 |
rural areas | 17 |
studies using | 17 |
benchmark dataset | 17 |
mhc molecules | 17 |
open reading | 17 |
positive results | 17 |
digital subtraction | 17 |
time rt | 17 |
taken together | 17 |
present within | 17 |
old drugs | 17 |
diagnostic imaging | 17 |
complete inactivation | 17 |
traditional chinese | 17 |
low ph | 17 |
control group | 17 |
athens gr | 17 |
even though | 17 |
slice ct | 17 |
current study | 17 |
emergency department | 17 |
spatial resolution | 16 |
nucleic acids | 16 |
mechanical ventilation | 16 |
pigs infected | 16 |
first time | 16 |
soiled bedding | 16 |
des infections | 16 |
like fold | 16 |
es learning | 16 |
covalent inhibitors | 16 |
highly conserved | 16 |
diabetes mellitus | 16 |
kda antigen | 16 |
two different | 16 |
bovine serum | 16 |
community outbreak | 16 |
commonly used | 16 |
patients without | 16 |
general public | 16 |
smallpox vaccination | 16 |
antigen presentation | 16 |
hypothetical protein | 16 |
ctl response | 16 |
recent studies | 16 |
goat anti | 16 |
ccl mice | 16 |
blot analysis | 16 |
radiation dose | 16 |
quality control | 16 |
enhanced ct | 16 |
public places | 16 |
antiviral drugs | 16 |
chest radiography | 16 |
convalescent serum | 16 |
detector row | 16 |
basal ganglia | 16 |
diagnostic value | 16 |
infected pigs | 16 |
radiofrequency ablation | 16 |
infected ccl | 15 |
ml sec | 15 |
blood samples | 15 |
binding domain | 15 |
gel electrophoresis | 15 |
es purpose | 15 |
monkey kidney | 15 |
contrast media | 15 |
like receptor | 15 |
hiv aids | 15 |
quality assurance | 15 |
progeny virus | 15 |
age years | 15 |
cases showed | 15 |
ot helices | 15 |
major outbreak | 15 |
neutralizing activity | 15 |
japanese encephalitis | 15 |
astral dataset | 15 |
vertebral artery | 15 |
health professions | 15 |
force microscopy | 15 |
host cells | 15 |
pulmonary embolism | 15 |
within hours | 15 |
antiviral agents | 15 |
viral entry | 15 |
accurate diagnosis | 15 |
portal vein | 15 |
syndrome identification | 15 |
rat liver | 15 |
following mhv | 15 |
amoy gardens | 15 |
significant correlation | 15 |
final diagnosis | 15 |
radiologic findings | 15 |
fusion protein | 15 |
subgenomic rna | 15 |
last years | 15 |
lipid bilayers | 15 |
acid sequences | 15 |
radiological appearances | 15 |
pediatric patients | 15 |
preventive behavior | 15 |
population health | 15 |
may help | 15 |
gastroenteritis virus | 15 |
cultured cells | 15 |
general population | 15 |
clinical progression | 15 |
healthcare system | 15 |
causative agent | 15 |
whole blood | 15 |
cov pneumonia | 15 |
antiviral activity | 15 |
pigment epithelial | 15 |
ivc systems | 15 |
renal failure | 15 |
clinical practice | 15 |
hydrophobic mismatch | 15 |
chemical warfare | 15 |
model viruses | 15 |
six patients | 15 |
described previously | 15 |
blood supply | 15 |
high sensitivity | 15 |
two radiologists | 15 |
gold standard | 15 |
interstitial pneumonia | 15 |
viral genome | 15 |
per day | 15 |
isolator cages | 15 |
mri findings | 15 |
whole virus | 14 |
diagnostic tests | 14 |
tissue culture | 14 |
acute diarrhea | 14 |
pcr analysis | 14 |
sex hormone | 14 |
less likely | 14 |
wear facemasks | 14 |
least three | 14 |
cytokine production | 14 |
par les | 14 |
significantly associated | 14 |
obtained using | 14 |
virus clearance | 14 |
binding globulin | 14 |
sendai virus | 14 |
lung injury | 14 |
virus matrix | 14 |
uk purpose | 14 |
remaining patients | 14 |
rsv bronchiolitis | 14 |
buffered saline | 14 |
five patients | 14 |
protective equipment | 14 |
highly contagious | 14 |
bilayer thickness | 14 |
coronavirus isolates | 14 |
much less | 14 |
strains isolated | 14 |
virus entry | 14 |
illumination intensity | 14 |
radiation exposure | 14 |
ivc system | 14 |
envelope glycoprotein | 14 |
cd cd | 14 |
single transmembrane | 14 |
wd strains | 14 |
virus strains | 14 |
binding constants | 14 |
lung pathology | 14 |
rna genome | 14 |
point scale | 14 |
positive predictive | 14 |
high level | 14 |
detect sars | 14 |
early stage | 14 |
artery disease | 14 |
th century | 14 |
early detection | 14 |
previously described | 14 |
small molecules | 14 |
multislice ct | 14 |
leukocytic interferon | 14 |
virus isolation | 14 |
mhc antigen | 14 |
marrow transplantation | 14 |
enhanced mr | 14 |
mr findings | 14 |
envelope protein | 14 |
binding affinity | 14 |
may lead | 14 |
human rpe | 14 |
state anxiety | 14 |
million people | 14 |
cov specific | 14 |
avoiding people | 14 |
sars preventive | 14 |
logistic regression | 14 |
global spread | 14 |
pathologic correlation | 14 |
enveloped rna | 14 |
results indicate | 14 |
hmpv infection | 14 |
insect cells | 14 |
nested primers | 14 |
culture medium | 14 |
phase contrast | 14 |
static isolator | 14 |
acute encephalitis | 14 |
strand rna | 14 |
subtraction angiography | 14 |
sars patient | 14 |
chest ct | 14 |
sulfur mustard | 14 |
molecular epidemiology | 14 |
brush border | 13 |
ace activity | 13 |
binding pockets | 13 |
hypervariable region | 13 |
clinical findings | 13 |
innate immune | 13 |
wall thickening | 13 |
ibv isolates | 13 |
section ct | 13 |
tr purpose | 13 |
light source | 13 |
results suggest | 13 |
selected cases | 13 |
high voltage | 13 |
au cours | 13 |
two ts | 13 |
human brain | 13 |
viral inactivation | 13 |
integral membrane | 13 |
much higher | 13 |
crystalline phase | 13 |
ace inhibitors | 13 |
enhanced mri | 13 |
disease virus | 13 |
molecular weight | 13 |
high risk | 13 |
signal peptide | 13 |
validation studies | 13 |
dually infected | 13 |
hepatocellular carcinoma | 13 |
index patient | 13 |
general hospital | 13 |
case definitions | 13 |
protein expression | 13 |
inflammatory cytokines | 13 |
coronavirus strain | 13 |
increased il | 13 |
trp residues | 13 |
nerve agent | 13 |
financial strain | 13 |
mm collimation | 13 |
query protein | 13 |
host range | 13 |
days later | 13 |
toronto area | 13 |
ot helix | 13 |
findings suggest | 13 |
years old | 13 |
headgroup region | 13 |
clinical suspicion | 13 |
study period | 13 |
target protein | 13 |
electricity consumption | 13 |
power doppler | 13 |
early stages | 13 |
vaccine candidates | 13 |
facemask wearing | 13 |
multidetector ct | 13 |
may occur | 13 |
mr angiography | 13 |
cell carcinoma | 13 |
specific antibody | 13 |
intravenous immunoglobulin | 13 |
human serum | 13 |
heart rate | 13 |
personal protective | 13 |
market development | 13 |
smallpox virus | 13 |
virus rna | 13 |
two years | 13 |
final concentration | 13 |
terminal domain | 13 |
chronic stress | 13 |
cell death | 13 |
enveloped virus | 13 |
protein mj | 13 |
negative results | 13 |
lactate dehydrogenase | 13 |
ml min | 13 |
human rhinovirus | 13 |
cellular receptors | 13 |
sars pneumonia | 13 |
pathological findings | 13 |
common cold | 13 |
methylene blue | 13 |
glycosylation sites | 12 |
healthcare systems | 12 |
wt virus | 12 |
plus ribavirin | 12 |
detection rate | 12 |
reported cases | 12 |
phosphatidic acid | 12 |
stem cells | 12 |
patients showed | 12 |
ag ml | 12 |
mosquito vectors | 12 |
young adults | 12 |
proinflammatory cytokines | 12 |
air trapping | 12 |
catalytic triad | 12 |
specific cd | 12 |
increased risk | 12 |
molecular basis | 12 |
virus strain | 12 |
virus vaccines | 12 |
bone scintigraphy | 12 |
catastrophic antiphospholipid | 12 |
long axis | 12 |
structure information | 12 |
functional sites | 12 |
guided biopsy | 12 |
stool samples | 12 |
central air | 12 |
neuronal degeneration | 12 |
high signal | 12 |
cell count | 12 |
results showed | 12 |
mononuclear cells | 12 |
economic growth | 12 |
cellular receptor | 12 |
femoral head | 12 |
rapid diagnosis | 12 |
health initiatives | 12 |
results show | 12 |
will help | 12 |
gold particles | 12 |
different types | 12 |
pathological conditions | 12 |
aerospace medicine | 12 |
greater toronto | 12 |
neurotropic coronavirus | 12 |
respiratory infection | 12 |
diarrhoea virus | 12 |
sequence similarity | 12 |
per person | 12 |
viral respiratory | 12 |
lymphocyte subsets | 12 |
int csr | 12 |
st century | 12 |
active sites | 12 |
phosphate buffer | 12 |
yellow fever | 12 |
necrosis factor | 12 |
endovascular treatment | 12 |
staphylococcus aureus | 12 |
limb paralysis | 12 |
sars threat | 12 |
human coronaviruses | 12 |
near future | 12 |
two separate | 12 |
blood vessels | 12 |
associated sars | 12 |
molecular strip | 12 |
hand hygiene | 12 |
postulates fulfilled | 12 |
pancreatic duct | 12 |
false negative | 12 |
terminal amino | 12 |
east asia | 12 |
dynamics simulations | 12 |
respiratory virus | 12 |
pl purpose | 12 |
weighted mr | 12 |
binding constant | 12 |
first step | 12 |
exhibit will | 12 |
newly emerging | 12 |
phylogenetic analysis | 12 |
human retinal | 12 |
confirmed cases | 12 |
analysis showed | 12 |
tnbp tween | 12 |
experimentally infected | 12 |
wall thickness | 12 |
congestive heart | 12 |
growth factor | 12 |
pulmonary nodules | 12 |
remyelinated axons | 12 |
mice immunized | 12 |
antibody production | 12 |
nine patients | 12 |
viruses isolated | 12 |
coping strategies | 12 |
among adults | 12 |
high degree | 12 |
fusion core | 12 |
health authorities | 12 |
primer sets | 12 |
may provide | 12 |
family members | 12 |
lupus anticoagulants | 12 |
ct data | 12 |
rpe cell | 12 |
clinical health | 12 |
clinical data | 12 |
viral pathogens | 12 |
turbo spin | 12 |
regression analysis | 12 |
lateral columns | 12 |
standard deviation | 12 |
molecular surface | 12 |
term outcomes | 12 |
years ago | 12 |
high mortality | 12 |
adaptive immune | 12 |
results presented | 12 |
one study | 11 |
hepatic artery | 11 |
imaging appearances | 11 |
protein data | 11 |
i mhc | 11 |
acyl chain | 11 |
effective vaccine | 11 |
preliminary results | 11 |
national taiwan | 11 |
lipid molecules | 11 |
domestic cats | 11 |
us images | 11 |
antibody test | 11 |
recombinant protein | 11 |
peptide substrates | 11 |
serine proteases | 11 |
epithelial cell | 11 |
unpublished data | 11 |
secondary structure | 11 |
coronary arteries | 11 |
pulmonary function | 11 |
hospitalized patients | 11 |
within min | 11 |
cov main | 11 |
plain radiographs | 11 |
confirmed sars | 11 |
imaging facility | 11 |
aids patients | 11 |
hindlimb paralysis | 11 |
table i | 11 |
hiv protease | 11 |
lung samples | 11 |
receptor binding | 11 |
dna sequencing | 11 |
national health | 11 |
may affect | 11 |
blocking elisa | 11 |
nasopharyngeal specimens | 11 |
surface points | 11 |
vaccine seed | 11 |
immunocompromised patients | 11 |
rotavirus gastroenteritis | 11 |
hydrophobic stretch | 11 |
sars pseudoviruses | 11 |
moral values | 11 |
murine hepatitis | 11 |
reference virus | 11 |
pulmonary hypertension | 11 |
serine protease | 11 |
target proteins | 11 |
significant reduction | 11 |
following transplantation | 11 |
membrane glycoprotein | 11 |
might also | 11 |
clinical prevention | 11 |
may contribute | 11 |
viral culture | 11 |
disease activity | 11 |
mice housed | 11 |
may cause | 11 |
perceived susceptibility | 11 |
protein vp | 11 |
brain injury | 11 |
cardiac surgery | 11 |
european union | 11 |
terminal ileum | 11 |
lg ml | 11 |
poor countries | 11 |
retrospective study | 11 |
correctly recognized | 11 |
newly discovered | 11 |
model virus | 11 |
age groups | 11 |
pet ct | 11 |
recent years | 11 |
mammalian cells | 11 |
viruses related | 11 |
clinical outcome | 11 |
bronchiolitis obliterans | 11 |
study using | 11 |
nm ss | 11 |
pulmonary disease | 11 |
protein interactions | 11 |
communicable disease | 11 |
multidetector row | 11 |
pulmonary emboli | 11 |
animal studies | 11 |
side chains | 11 |
pcr amplification | 11 |
transmembrane helices | 11 |
rural households | 11 |
three months | 11 |
hiv infection | 11 |
positive control | 11 |
hiv hcv | 11 |
uterine leiomyomas | 11 |
normal human | 11 |
sars may | 11 |
among persons | 11 |
positive samples | 11 |
apical membrane | 11 |
pulmonary arteries | 11 |
quantitative analysis | 11 |
negative predictive | 11 |
genetic reassortment | 11 |
poliovirus vaccine | 11 |
outpatient visits | 11 |
forest virus | 11 |
applied biosystems | 11 |
healthy volunteers | 11 |
virus isolated | 11 |
tumor size | 11 |
functional groups | 11 |
acute lung | 11 |
many years | 11 |
transplant recipients | 11 |
binding assay | 11 |
positive cells | 11 |
single amino | 11 |
routine use | 11 |
proteolytic cleavage | 11 |
electron microscope | 11 |
specific primer | 11 |
animal health | 11 |
chain length | 11 |
transmission potential | 11 |
interferon alfa | 11 |
comparative study | 11 |
bovine viral | 11 |
virus isolates | 11 |
risk factor | 11 |
oral anticoagulation | 11 |
like activity | 11 |
golgi apparatus | 11 |
large numbers | 11 |
negative control | 11 |
body temperature | 11 |
currently available | 11 |
fever virus | 11 |
additional information | 11 |
cov rna | 11 |
secondary infections | 11 |
respiratory infections | 11 |
semliki forest | 11 |
taiwan university | 11 |
situ hybridization | 11 |
mg kg | 11 |
patients infected | 11 |
interventional radiology | 11 |
early identification | 11 |
epidemic curve | 11 |
respiratory pathogens | 11 |
vaccine strain | 10 |
diagnostic tool | 10 |
marrow edema | 10 |
acute gastroenteritis | 10 |
ct examinations | 10 |
recent study | 10 |
du virus | 10 |
new disease | 10 |
intravenous administration | 10 |
results indicated | 10 |
acute infectious | 10 |
high dose | 10 |
health promotion | 10 |
rectal cancer | 10 |
flow rate | 10 |
clinical evaluation | 10 |
several years | 10 |
electricity markets | 10 |
rat anti | 10 |
cov load | 10 |
analysis using | 10 |
horseradish peroxidase | 10 |
cd lymphocytes | 10 |
resolution ct | 10 |
informed consent | 10 |
probable case | 10 |
guided core | 10 |
kwd strains | 10 |
ibv strains | 10 |
hospital admission | 10 |
phase transition | 10 |
antibody titers | 10 |
highly sensitive | 10 |
emerging disease | 10 |
rat brain | 10 |
health officials | 10 |
also used | 10 |
occluded surface | 10 |
four cases | 10 |
various imaging | 10 |
health professional | 10 |
personal communication | 10 |
whole body | 10 |
three groups | 10 |
disease outbreak | 10 |
chinese herbal | 10 |
healthy people | 10 |
dose distribution | 10 |
global alert | 10 |
angiotensin system | 10 |
patient sera | 10 |
cells infected | 10 |
artery stenosis | 10 |
previously reported | 10 |
variola virus | 10 |
nucleotide sequences | 10 |
data analysis | 10 |
protease inhibitor | 10 |
protein sequences | 10 |
radiologic features | 10 |
elisa method | 10 |
low attenuation | 10 |
virus load | 10 |
herpes simplex | 10 |
virus may | 10 |
three types | 10 |
renal masses | 10 |
virus culture | 10 |
mediated remyelination | 10 |
vascular malformations | 10 |
healthy adults | 10 |
us findings | 10 |
estimation procedure | 10 |
onset date | 10 |
mm caprylate | 10 |
plain film | 10 |
days post | 10 |
mm hg | 10 |
solvent detergent | 10 |
mr sequences | 10 |
les plus | 10 |
hydrophobic region | 10 |
local health | 10 |
dendritic cell | 10 |
viral diarrhoea | 10 |
two doses | 10 |
images showed | 10 |
low signal | 10 |
function tests | 10 |
le diagnostic | 10 |
like receptors | 10 |
magnetic field | 10 |
late domain | 10 |
binding ability | 10 |
disease outbreaks | 10 |
correct diagnosis | 10 |
human rotavirus | 10 |
people perceived | 10 |
index case | 10 |
lung disease | 10 |
etiologic agent | 10 |
may need | 10 |
pulmonary artery | 10 |
mouse igg | 10 |
laboratory tests | 10 |
vast majority | 10 |
causal agent | 10 |
signal sequence | 10 |
fluorescence quenching | 10 |
hcv genotype | 10 |
will continue | 10 |
diffusion tensor | 10 |
take place | 10 |
interferon alpha | 10 |
bowel wall | 10 |
i antigen | 10 |
social support | 10 |
abdominal aortic | 10 |
corona virus | 10 |
pseudorabies virus | 10 |
mutations associated | 10 |
radiological findings | 10 |
international quarantine | 10 |
border membrane | 10 |
london uk | 10 |
csr sars | 10 |
left ventricle | 10 |
syndrome sars | 10 |
diffuse alveolar | 10 |
medical systems | 10 |
tagged recombinant | 10 |
igg antibody | 10 |
per capita | 10 |
target sars | 10 |
ct examination | 10 |
chronic demyelination | 10 |
glass attenuation | 10 |
clinical virology | 10 |
one year | 10 |
one hundred | 10 |
data presented | 10 |
acute illness | 10 |
ill sars | 10 |
vero cell | 10 |
du sras | 10 |
acute bronchiolitis | 10 |
seoul kr | 10 |
synthetic peptides | 10 |
prognostic factors | 10 |
molecular characterization | 10 |
mhc antigens | 10 |
imaging techniques | 10 |
taqman rt | 10 |
barium enema | 10 |
false positives | 10 |
intestinal epithelial | 10 |
transmission dynamics | 10 |
barr virus | 9 |
mr examinations | 9 |
en el | 9 |
may increase | 9 |
side effects | 9 |
coronavirus rna | 9 |
also included | 9 |
episodes per | 9 |
false positive | 9 |
national institute | 9 |
significantly different | 9 |
cause disease | 9 |
va flow | 9 |
postmortem lung | 9 |
warfare agents | 9 |
pivotal role | 9 |
culture supernatants | 9 |
virus using | 9 |
vaccine production | 9 |
binding partners | 9 |
samples obtained | 9 |
asian countries | 9 |
sur les | 9 |
discovery process | 9 |
expression vector | 9 |
equine encephalomyelitis | 9 |
determined using | 9 |
global outbreak | 9 |
healthy body | 9 |
receptor agonists | 9 |
emergency response | 9 |
diffusion weighted | 9 |
cov disease | 9 |
perceived barriers | 9 |
data collection | 9 |
small renal | 9 |
demographic characteristics | 9 |
disease severity | 9 |
transcriptase polymerase | 9 |
boundary lipids | 9 |
see ref | 9 |
inflammatory cytokine | 9 |
chinese government | 9 |
infection network | 9 |
viral diseases | 9 |
information age | 9 |
study design | 9 |
electron microscopic | 9 |
occlusive disease | 9 |
coronavirus infections | 9 |
gastroenteritis coronavirus | 9 |
membrane association | 9 |
peptidase activity | 9 |
please refer | 9 |
strains including | 9 |
hydrophobic matching | 9 |
cognitive screening | 9 |
cba ht | 9 |
ccl signaling | 9 |
acute infection | 9 |
two proteins | 9 |
protein might | 9 |
high levels | 9 |
species barrier | 9 |
genomic sequence | 9 |
image findings | 9 |
fold increase | 9 |
smallpox vaccine | 9 |
stranded rna | 9 |
abdominal pain | 9 |
mr spectroscopy | 9 |
tract infection | 9 |
epizootic strains | 9 |
affected countries | 9 |
viral antigens | 9 |
molecular mechanisms | 9 |
human pathogens | 9 |
primary cause | 9 |
medical imaging | 9 |
protein concentration | 9 |
various types | 9 |
cov genome | 9 |
histidine residues | 9 |
oral route | 9 |
cervical carcinoma | 9 |
rough surface | 9 |
close contacts | 9 |
special administrative | 9 |
chronic obstructive | 9 |
imaging technique | 9 |
covalent inhibitor | 9 |
health protection | 9 |
three cases | 9 |
respiratory secretions | 9 |
presenting cells | 9 |
reading frames | 9 |
may result | 9 |
new world | 9 |
blot competition | 9 |
adult patients | 9 |
additional studies | 9 |
local transmission | 9 |
ct features | 9 |
converting enzymes | 9 |
hmgb antibodies | 9 |
fluid collection | 9 |
minimally invasive | 9 |
igg antibodies | 9 |
characteristic imaging | 9 |
mb narrow | 9 |
may reflect | 9 |
reading frame | 9 |
health measures | 9 |
type virus | 9 |
kindly provided | 9 |
rural market | 9 |
multislice computed | 9 |
binding proteins | 9 |
american community | 9 |
depressive symptoms | 9 |
may require | 9 |
common mutations | 9 |
animal reservoir | 9 |
pcr system | 9 |
nasopharyngeal secretions | 9 |
color duplex | 9 |
infection networks | 9 |
small molecule | 9 |
african green | 9 |
kr purpose | 9 |
impairment following | 9 |
ground glass | 9 |
viral envelope | 9 |
positively charged | 9 |
inclusion bodies | 9 |
viral structural | 9 |
weighted sequences | 9 |
molecular diagnostics | 9 |
touchdown protocol | 9 |
catalytic residues | 9 |
mortality rates | 9 |
serum sample | 9 |
wearing facemasks | 9 |
curriculum framework | 9 |
molecular mass | 9 |
prv alone | 9 |
transmission electron | 9 |
diagnostic test | 9 |
methods used | 9 |
retinoic acid | 9 |
normal subjects | 9 |
rural electrification | 9 |
obstructive pulmonary | 9 |
oral administration | 9 |
cell receptor | 9 |
occurred among | 9 |
sample preparation | 9 |
faecal samples | 9 |
world war | 9 |
chemical toxicity | 9 |
virus particle | 9 |
severe disease | 9 |
dna polymerase | 9 |
month follow | 9 |
malignant lesions | 9 |
present time | 9 |
hand washing | 9 |
helical hairpin | 9 |
possible role | 9 |
experimental allergic | 9 |
helix bundle | 9 |
daily living | 9 |
see table | 9 |
transplanted cells | 9 |
medical research | 9 |
human respiratory | 9 |
sars vaccine | 9 |
bl mice | 9 |
kong special | 9 |
brain lesions | 9 |
electricity intensity | 9 |
san diego | 9 |
lower extremity | 9 |
coronaviridae family | 9 |
lopinavir ritonavir | 9 |
total rna | 9 |
total cell | 9 |
two main | 9 |
infected individuals | 9 |
nasal swabs | 9 |
patients may | 9 |
surgical resection | 9 |
ace protein | 9 |
patients undergoing | 9 |
committed progenitors | 9 |
plasma products | 9 |
less frequently | 9 |
neutralization assay | 9 |
air travel | 9 |
allergic encephalomyelitis | 9 |
sore throat | 9 |
benign lesions | 9 |
energy minimization | 9 |
group pigs | 9 |
putative origins | 9 |
double contrast | 9 |
clinical specimens | 9 |
health emergency | 9 |
administrative region | 9 |
typical findings | 9 |
typhoid vaccination | 9 |
high frequency | 9 |
care system | 9 |
effective treatment | 9 |
fusion activity | 9 |
animal species | 9 |
imaging studies | 9 |
foreign bodies | 9 |
giant pandas | 9 |
random primer | 9 |
low levels | 9 |
ultrasound guided | 9 |
apparent diffusion | 9 |
surface glycoprotein | 9 |
functional site | 9 |
fetal bovine | 9 |
actin filaments | 9 |
acid substitutions | 9 |
pandemic strains | 9 |
biological weapons | 9 |
jp learning | 9 |
perfusion ct | 9 |
among patients | 9 |
plain films | 9 |
recent sars | 9 |
toxoplasma gondii | 9 |
six provinces | 9 |
body fluids | 9 |
peptide elisa | 9 |
infectious diarrheas | 9 |
plasmids encoding | 9 |
gene encoding | 9 |
protein surface | 9 |
well known | 9 |
human hosts | 9 |
capsid protein | 9 |
serum albumin | 9 |
cases occurred | 9 |
long term | 9 |
manufacturing processes | 9 |
sars outbreaks | 9 |
new virus | 9 |
igg abs | 9 |
first week | 9 |
soft tissues | 9 |
liver specific | 9 |
protein binding | 9 |
high incidence | 9 |
tumor necrosis | 8 |
pneumonic sars | 8 |
chemical properties | 8 |
ang i | 8 |
cell transplantation | 8 |
conformational changes | 8 |
disease onset | 8 |
small intestine | 8 |
using color | 8 |
scan time | 8 |
cov infections | 8 |
crisis management | 8 |
adult human | 8 |
first round | 8 |
venous thrombosis | 8 |
boundary lipid | 8 |
plasma levels | 8 |
primary infection | 8 |
cov spike | 8 |
plain radiography | 8 |
spanish influenza | 8 |
poly di | 8 |
samples collected | 8 |
cells isolated | 8 |
ionising radiation | 8 |
two molecules | 8 |
china statistical | 8 |
madrid es | 8 |
lesser extent | 8 |
left ventricular | 8 |
blocking effect | 8 |
ace antibody | 8 |
analysis revealed | 8 |
relatively low | 8 |
cognitive function | 8 |
urgent need | 8 |
sulphate precipitation | 8 |
il est | 8 |
respiratory specimens | 8 |
kidney cells | 8 |
detector ct | 8 |
lymphocyte count | 8 |
pelvic floor | 8 |
positive patients | 8 |
mri showed | 8 |
multicystic dysplastic | 8 |
genotype iv | 8 |
conducted using | 8 |
human population | 8 |
genomic rna | 8 |
order parameter | 8 |
gel phase | 8 |
healthy young | 8 |
national university | 8 |
low dose | 8 |
humoral responses | 8 |
immunologically naive | 8 |
hospital discharge | 8 |
washing buffer | 8 |
weighted imaging | 8 |
medical conditions | 8 |
tissue distribution | 8 |
iv contrast | 8 |
binding patterns | 8 |
imaging characteristics | 8 |
ace homolog | 8 |
obstructive lesions | 8 |
naturally occurring | 8 |
cystic masses | 8 |
common cause | 8 |
controlled trial | 8 |
rotavirus antigen | 8 |
radiation protection | 8 |
care worker | 8 |
conservative treatment | 8 |
treatment protocol | 8 |
severe stenosis | 8 |
buenos aires | 8 |
developed countries | 8 |
primary care | 8 |
negative staining | 8 |
neutralization test | 8 |
six months | 8 |
image reconstruction | 8 |
abdominal aorta | 8 |
enzyme activity | 8 |
relative binding | 8 |
fever onset | 8 |
surgical intervention | 8 |
etiological agent | 8 |
comparative full | 8 |
roc curve | 8 |
following icu | 8 |
korean wd | 8 |
thoracic ct | 8 |
protein contains | 8 |
van den | 8 |
progenitor cells | 8 |
signal intensities | 8 |
ammonium sulphate | 8 |
monitoring methods | 8 |
animal viruses | 8 |
enteric tropism | 8 |
fr learning | 8 |
health policy | 8 |
clinical trial | 8 |
nmda receptor | 8 |
addressed include | 8 |
flow cytometry | 8 |
conditioning system | 8 |
hospitalized children | 8 |
normal values | 8 |
amide i | 8 |
virus fusion | 8 |
key role | 8 |
synthetic peptide | 8 |
perceived benefits | 8 |
transmission cycle | 8 |
serological evidence | 8 |
xenopus oocytes | 8 |
cell membrane | 8 |
ivc rack | 8 |
des cas | 8 |
primary case | 8 |
viral simulant | 8 |
infection among | 8 |
thessaloniki gr | 8 |
also detected | 8 |
photosynthetic reaction | 8 |
nucleotide sequence | 8 |
high mobility | 8 |
past years | 8 |
standard dosimetry | 8 |
next influenza | 8 |
side chain | 8 |
radiological features | 8 |
four groups | 8 |
express class | 8 |
prevent sars | 8 |
major cause | 8 |
thoracic aorta | 8 |
mobility group | 8 |
congenital heart | 8 |
osaka jp | 8 |
new cases | 8 |
microglial cells | 8 |
health professionals | 8 |
fat suppression | 8 |
second round | 8 |
functional characterization | 8 |
domestic cat | 8 |
coiled coil | 8 |
structural features | 8 |
good policy | 8 |
differential diagnoses | 8 |
dual infection | 8 |
disease transmission | 8 |
structural genomics | 8 |
cells present | 8 |
within two | 8 |
duplex sonography | 8 |
vaccination program | 8 |
cerebral infarction | 8 |
proximal tubule | 8 |
cysteine residues | 8 |
transmembrane domains | 8 |
alveolar damage | 8 |
recombinant baculoviruses | 8 |
winter dysentery | 8 |
human ace | 8 |
avoiding public | 8 |
contingency planning | 8 |
nasopharyngeal aspirate | 8 |
domestic animals | 8 |
basic protein | 8 |
anthrax attacks | 8 |
three major | 8 |
internal carotid | 8 |
nagoya jp | 8 |
virus vp | 8 |
estrogen receptor | 8 |
suspected sars | 8 |
two helices | 8 |
mm cranial | 8 |
tyrosine kinase | 8 |
embryonic stem | 8 |
critical role | 8 |
target cells | 8 |
virus budding | 8 |
langerhans cell | 8 |
data bank | 8 |
scoring system | 8 |
good manufacturing | 8 |
digital radiography | 8 |
significant predictors | 8 |
gestational age | 8 |
chicken eggs | 8 |
common respiratory | 8 |
respiratory coronavirus | 8 |
fatality rate | 8 |
mtmc hypothesis | 8 |
acid ph | 8 |
dna vaccine | 8 |
influenza activity | 8 |
imaging method | 8 |
mebus strain | 8 |
clinical samples | 8 |
mm caudal | 8 |
axial images | 8 |
molecular interactions | 8 |
aortic aneurysm | 8 |
ms patients | 8 |
persistent infection | 8 |
randomly selected | 8 |
gr learning | 8 |
chez les | 8 |
mg day | 8 |
unknown etiology | 8 |
perceived severity | 8 |
biosafety level | 8 |
brain sections | 8 |
heterologous gene | 8 |
report avoiding | 8 |
contrast images | 8 |
normal cns | 8 |
hydrocarbon core | 8 |
cytokine responses | 8 |
care providers | 8 |
among poultry | 8 |
highly potent | 8 |
highly efficient | 8 |
cells may | 8 |
flow volumes | 8 |
disease associated | 8 |
reverse transcribed | 8 |
length genome | 8 |
neutralizing epitopes | 8 |
molecular assays | 8 |
better understand | 8 |
controlled trials | 8 |
abnormal findings | 8 |
type iii | 8 |
budapest hu | 8 |
protein synthesis | 8 |
well defined | 8 |
phase serum | 8 |
mycoplasma pneumoniae | 8 |
transfected cells | 8 |
clinical assessment | 8 |
sectional imaging | 8 |
brain tumors | 8 |
preventive services | 8 |
may play | 8 |
may include | 8 |
pattern recognition | 8 |
virus neutralization | 8 |
weighted spin | 8 |
emerging diseases | 8 |
leukemia virus | 8 |
diffusion coefficient | 8 |
clinical characteristics | 8 |
upper abdomen | 8 |
ovarian cancer | 8 |
plaque reduction | 8 |
confidence interval | 8 |
test article | 8 |
calcaneal spur | 8 |
overall sensitivity | 8 |
another example | 8 |
highly infectious | 8 |
new method | 8 |
herniation pit | 8 |
organ transplantation | 8 |
syndrome severe | 8 |
pleural effusions | 8 |
dependent protein | 8 |
also showed | 8 |
single slice | 8 |
antibody titres | 8 |
attributable risk | 8 |
attack rate | 8 |
drosophila melanogaster | 8 |
sequence alignment | 8 |
van der | 8 |
blood group | 8 |
chester disease | 8 |
mouse model | 8 |
molecular cloning | 8 |
myelin basic | 8 |
different levels | 8 |
mm naci | 8 |
also demonstrated | 8 |
learning objective | 8 |
recent report | 8 |
aedes aegypti | 8 |
dna vaccines | 8 |
lesions showed | 8 |
supine position | 8 |
patients presenting | 8 |
cell lysate | 8 |
dynamic study | 8 |
peripheral arterial | 8 |
response rate | 8 |
pbs containing | 8 |
protein families | 8 |
cytoplasmic side | 8 |
hospital stay | 8 |
filters placed | 8 |
serial online | 8 |
control study | 8 |
metapneumovirus infection | 8 |
mass index | 7 |
cell histiocytosis | 7 |
fatal severe | 7 |
fisher scientific | 7 |
ctl epitope | 7 |
first days | 7 |
primer master | 7 |
specimens obtained | 7 |
ece homolog | 7 |
respiratoire aigu | 7 |
medical fees | 7 |
supernatant fluids | 7 |
hmpv isolates | 7 |
known protein | 7 |
new coronavirus | 7 |
microbiological monitoring | 7 |
enzootic strains | 7 |
cohort study | 7 |
copies ml | 7 |
hydatid disease | 7 |
recombinant vaccinia | 7 |
drug targets | 7 |
contagious disease | 7 |
table shows | 7 |
standard protocol | 7 |
five components | 7 |
much lower | 7 |
sera samples | 7 |
first incubation | 7 |
infected persons | 7 |
clinical examination | 7 |
interobserver variability | 7 |
case report | 7 |
five years | 7 |
liver lesions | 7 |
heterologous genes | 7 |
may suggest | 7 |
data acquisition | 7 |
mhv model | 7 |
adult chinese | 7 |
clinical application | 7 |
alveolar macrophages | 7 |
san francisco | 7 |
ligand binding | 7 |
broad spectrum | 7 |
using anti | 7 |
health threats | 7 |
viral reduction | 7 |
sur le | 7 |
peripheral lung | 7 |
diarrheal diseases | 7 |
tumor volume | 7 |
alternative approach | 7 |
produced using | 7 |
sicca syndrome | 7 |
torpedo marmorata | 7 |
mtmc drugs | 7 |
previously healthy | 7 |
mm thick | 7 |
mrna expression | 7 |
lublin pl | 7 |
health action | 7 |
cmk peptide | 7 |
touchdown pcr | 7 |
chinese medicine | 7 |
statistical publishing | 7 |
recombinant spike | 7 |
laboratory findings | 7 |
cp ro | 7 |
des voies | 7 |
porphyromonas gingivalis | 7 |
effective inactivation | 7 |
health departments | 7 |
ionization chamber | 7 |
laboratory animal | 7 |
developed world | 7 |
squamous cell | 7 |
voltage static | 7 |
significantly reduced | 7 |
mhc molecule | 7 |
kr learning | 7 |
two days | 7 |
endopeptidase activity | 7 |
rough endoplasmic | 7 |
psychological stress | 7 |
intranuclear inclusion | 7 |
clinical diagnosis | 7 |
prrsv alone | 7 |
mb working | 7 |
axonal sparing | 7 |
colorectal polyps | 7 |
mean value | 7 |
lymphocyte apoptosis | 7 |
cyclospora oocysts | 7 |
candidate transformation | 7 |
routinely used | 7 |
kg gd | 7 |
ct guided | 7 |
resonance angiography | 7 |
group box | 7 |
focal liver | 7 |
deficient mice | 7 |
interventional procedures | 7 |
seroconverted groups | 7 |
cryptosporidium parvum | 7 |
international travel | 7 |
key components | 7 |
transgenic mice | 7 |
pcr product | 7 |
lead compounds | 7 |
photodynamic inactivation | 7 |
six cases | 7 |
cervical lymph | 7 |
causes severe | 7 |
vector laboratories | 7 |
newly identified | 7 |
old woman | 7 |
vp protein | 7 |
based reverse | 7 |
bile duct | 7 |
energy subtraction | 7 |
leading cause | 7 |
multiphase fusion | 7 |
also performed | 7 |
host disease | 7 |
viral agents | 7 |
leukocyte count | 7 |
microbial threats | 7 |
molecular techniques | 7 |
normal anatomy | 7 |
par une | 7 |
cerebral sparganosis | 7 |
clinic proceedings | 7 |
hcv co | 7 |
anionic phospholipid | 7 |
specific immune | 7 |
us purpose | 7 |
bind estradiol | 7 |
important factor | 7 |
least two | 7 |
studies indicate | 7 |
mainland china | 7 |
seed virus | 7 |
plasmid pet | 7 |
infusion chemotherapy | 7 |
probably due | 7 |
higher sensitivity | 7 |
equine herpesvirus | 7 |
iron oxide | 7 |
laboratory workers | 7 |
cellular processes | 7 |
den usa | 7 |
also contains | 7 |
amplification hosts | 7 |
study showed | 7 |
protein expressed | 7 |
ct appearances | 7 |
acid precipitation | 7 |
schwann cells | 7 |
washed twice | 7 |
general ward | 7 |
encephalitis viruses | 7 |
roche diagnostics | 7 |
disease prevention | 7 |
pleural thickening | 7 |
epidemiological determinants | 7 |
rf ablation | 7 |
epidemic size | 7 |
clinical settings | 7 |
neutralising antibody | 7 |
pcr reaction | 7 |
bilayer normal | 7 |
vitro activity | 7 |
synchrotron radiation | 7 |
patients presented | 7 |
groin pain | 7 |
epidemic duration | 7 |
glial cell | 7 |
analyzed using | 7 |
infectious peritonitis | 7 |
donated blood | 7 |
protective immunity | 7 |
significant effect | 7 |
copy number | 7 |
medical care | 7 |
clinical follow | 7 |
complete hindlimb | 7 |
central america | 7 |
best solutions | 7 |
multiplanar reconstructions | 7 |
ctl epitopes | 7 |
chemical agents | 7 |
months later | 7 |
torpedo kidney | 7 |
pepsin digestion | 7 |
cov may | 7 |
demand change | 7 |
acute aortic | 7 |
personal use | 7 |
herbal remedies | 7 |
annealing temperature | 7 |
factors affecting | 7 |
structural protein | 7 |
unpublished observations | 7 |
mhz linear | 7 |
epidemiologic data | 7 |
feline infectious | 7 |
extracellular domain | 7 |
health profession | 7 |
demyelinated axons | 7 |
publishing house | 7 |
seven days | 7 |
demand forecasting | 7 |
well plates | 7 |
adc values | 7 |
single patient | 7 |
medical students | 7 |
syndrome associated | 7 |
viral membrane | 7 |
major role | 7 |
log inactivation | 7 |
microtitre plates | 7 |
autopsy cases | 7 |
rack exhaust | 7 |
specific contrast | 7 |
chronic renal | 7 |
collecting system | 7 |
many cases | 7 |
viral disease | 7 |
many people | 7 |
female patients | 7 |
cellular tropism | 7 |
lead drape | 7 |
different binding | 7 |
hu purpose | 7 |
blood products | 7 |
disulfide bonds | 7 |
linear regression | 7 |
community transmission | 7 |
double blind | 7 |
term outcome | 7 |
contact tracing | 7 |
abdominal wall | 7 |
new influenza | 7 |
tract disease | 7 |
guided percutaneous | 7 |
health infrastructure | 7 |
mouse liver | 7 |
air sentinels | 7 |
virus challenge | 7 |
also known | 7 |
responses may | 7 |
imaging using | 7 |
porcine respiratory | 7 |
linked glycosylation | 7 |
monitoring program | 7 |
well documented | 7 |
acid molecule | 7 |
binding mode | 7 |
per ml | 7 |
slice spiral | 7 |
care facilities | 7 |
inflammatory drugs | 7 |
diagnostic criteria | 7 |
ge medical | 7 |
horizontal dose | 7 |
physical examination | 7 |
cancer patients | 7 |
kda form | 7 |
viral gastroenteritis | 7 |
acne vulgaris | 7 |
persons aged | 7 |
medical records | 7 |
simulated epidemic | 7 |
good luck | 7 |
matter tracts | 7 |
kidney membranes | 7 |
respiratory droplets | 7 |
genetic analysis | 7 |
old male | 7 |
borne viruses | 7 |
ultrasound examination | 7 |
findings include | 7 |
may become | 7 |
laboratory diagnosis | 7 |
downstream primer | 7 |
sars drugs | 7 |
superior oblique | 7 |
private sectors | 7 |
renal function | 7 |
image data | 7 |
induced demyelination | 7 |
data sets | 7 |
values obtained | 7 |
cleavage sites | 7 |
geometric hashing | 7 |
intellectual property | 7 |
coil embolization | 7 |
major complications | 7 |
angiotensinconverting enzyme | 7 |
report engaging | 7 |
complex mri | 7 |
inflammatory cells | 7 |
health threat | 7 |
invertebrate ace | 7 |
taqman probe | 7 |
wild poliovirus | 7 |
cells express | 7 |
epidemiological studies | 7 |
retroperitoneal cystic | 7 |
cutoff value | 7 |
less common | 7 |
lymphoid tissue | 7 |
ten patients | 7 |
rapidly evolving | 7 |
cells resulted | 7 |
male sex | 7 |
clinical value | 7 |
az sars | 7 |
studies suggest | 7 |
ibv antibodies | 7 |
des patients | 7 |
percutaneous drainage | 7 |
immunodominant epitope | 7 |
proteolytic processing | 7 |
standard treatment | 7 |
binding specificity | 7 |
haemagglutinin cleavage | 7 |
vascular dementia | 7 |
duck singapore | 7 |
actual values | 7 |
prrsv antigen | 7 |
pulmonary edema | 7 |
receptor antagonist | 7 |
varicose veins | 7 |
bronchial wall | 7 |
force microscope | 7 |
year old | 7 |
absorbed dose | 7 |
human services | 7 |
southeast asia | 7 |
forming units | 7 |
dangerous pathogens | 7 |
body mass | 7 |
high concentration | 7 |
ct reconstructions | 7 |
ts phenotype | 7 |
tlr antibody | 7 |
heavily glycosylated | 7 |
cell population | 7 |
new human | 7 |
temporal resolution | 7 |
mr examination | 7 |
seven patients | 7 |
raw data | 7 |
rheumatoid arthritis | 7 |
smooth muscle | 7 |
embryonated chicken | 7 |
effective dose | 7 |
normal range | 7 |
human infections | 7 |
enhancement pattern | 7 |
multiplex detection | 7 |
virus genome | 7 |
sialic acid | 7 |
renal arteries | 7 |
epidemiologic criteria | 7 |
thank dr | 7 |
doppler sonography | 7 |
biological materials | 7 |
upstream primer | 7 |
porcine circovirus | 7 |
rodents housed | 7 |
cardiovascular disease | 7 |
intravenous contrast | 7 |
serologic testing | 7 |
imatinib mesylate | 7 |
loaded onto | 7 |
axonal loss | 7 |
binding pocket | 7 |
ethidium bromide | 7 |
topics az | 7 |
subtraction system | 7 |
hindlimb weakness | 7 |
active disease | 7 |
acquisition time | 7 |
mgi ml | 7 |
respiratory diseases | 7 |
like illness | 7 |
phylogenetic analyses | 7 |
migratory birds | 7 |
median age | 7 |
kong identification | 7 |
hrct findings | 7 |
te ms | 7 |
showed high | 7 |
patient management | 7 |
diagnostic quality | 7 |
renal cell | 7 |
higher risk | 7 |
phylogenetic studies | 7 |
signaling pathways | 7 |
dual infections | 7 |
vaccine strains | 7 |
derived products | 7 |
antigen detection | 7 |
serological assays | 7 |
human sars | 7 |
receptor specificity | 7 |
aromatic residues | 7 |
four times | 7 |
phage particles | 7 |
mayo clinic | 7 |
tissue samples | 7 |
ph incubation | 7 |
ii major | 7 |
human cells | 7 |
human populations | 7 |
sars transmission | 7 |
sucrose gradients | 7 |
site residues | 7 |
weeks later | 7 |
sequence comparison | 7 |
demyelinating disease | 7 |
den hoogen | 7 |
completely kill | 7 |
les adv | 7 |
prevent contracting | 7 |
working group | 7 |
emerging economies | 7 |
melanogaster ace | 7 |
results may | 7 |
infections topics | 7 |
air purifying | 7 |
prevent transmission | 7 |
current knowledge | 7 |
tlr signaling | 7 |
arterial infusion | 7 |
various causes | 7 |
acid amplification | 7 |
lung diseases | 7 |
postmenopausal women | 7 |
blood transfusion | 7 |
health education | 7 |
full length | 7 |
uk infections | 7 |
birth asphyxia | 7 |
low level | 7 |
influenza pandemics | 7 |
clinical cases | 7 |
case i | 7 |
global public | 7 |
first described | 7 |
splenic lesions | 7 |
removal efficiency | 7 |
community visits | 7 |
colleagues noted | 7 |
chronically infected | 7 |
mammalian ace | 7 |
may explain | 7 |
inactivated influenza | 7 |
cancer detection | 7 |
biochemical pathways | 6 |
buffer containing | 6 |
mm thickness | 6 |
transabdominal ultrasonographic | 6 |
fast spin | 6 |
dose thin | 6 |
much shorter | 6 |
mr features | 6 |
cognitive functioning | 6 |
decision support | 6 |
neural precursors | 6 |
antivenom production | 6 |
molecular modeling | 6 |
atrial fibrillation | 6 |
internal mammary | 6 |
surgical findings | 6 |
stimulatory molecules | 6 |
frontal lobes | 6 |
aspartyl proteinases | 6 |
system may | 6 |
mean duration | 6 |
body weight | 6 |
le groupe | 6 |
communicable diseases | 6 |
underwent mri | 6 |
sybr green | 6 |
peritoneal seeding | 6 |
small aneurysms | 6 |
antiphospholipid antibodies | 6 |
mouth disease | 6 |
biologically active | 6 |
sars protease | 6 |
similar binding | 6 |
postexposure vaccination | 6 |
animal coronaviruses | 6 |
haematological manifestations | 6 |
may serve | 6 |
following vaccination | 6 |
patient group | 6 |
concentration contrast | 6 |
kell blood | 6 |
nasopharyngeal aspirates | 6 |
anatomical variations | 6 |
cumulative number | 6 |
functional significance | 6 |
mean tadc | 6 |
portal venous | 6 |
nerve agents | 6 |
invasive method | 6 |
flow velocity | 6 |
calcium score | 6 |
inversion recovery | 6 |
mri imaging | 6 |
aortic aneurysms | 6 |
virus families | 6 |
oblique muscles | 6 |
clinical resistance | 6 |
enhanced mra | 6 |
sars research | 6 |
systemic disease | 6 |
elisa methods | 6 |
cell activation | 6 |
protein bands | 6 |
birth weight | 6 |
high titer | 6 |
ace gene | 6 |
low grade | 6 |
cell responses | 6 |
hendra virus | 6 |
le plus | 6 |
alternative diagnosis | 6 |
mild illness | 6 |
molecular imaging | 6 |
therapeutic agents | 6 |
myocutaneous flap | 6 |
low concentrations | 6 |
pulmonary infiltrates | 6 |
labeled cells | 6 |
healthy controls | 6 |
virus vector | 6 |
one another | 6 |
several reports | 6 |
ab binding | 6 |
metropole hotel | 6 |
axons within | 6 |
leech theromyzon | 6 |
autogenous myocutaneous | 6 |
culture supernatant | 6 |
historical data | 6 |
bronchoalveolar lavage | 6 |
rabies virus | 6 |
mood responses | 6 |
bone fracture | 6 |
important roles | 6 |
perfusion studies | 6 |
hearing loss | 6 |
human oligodendrocytes | 6 |
different concentrations | 6 |
tnbp cholate | 6 |
cell number | 6 |
table ii | 6 |
left hand | 6 |
vaginal device | 6 |
however repressive | 6 |
cardiac ct | 6 |
endovascular repair | 6 |
early outbreak | 6 |
conserved among | 6 |
also observed | 6 |
language newspapers | 6 |
topics addressed | 6 |
exact test | 6 |
vivo substrates | 6 |
asymptomatic infection | 6 |
integral part | 6 |
healthcare information | 6 |
diagnostic possibilities | 6 |
innate immunity | 6 |
winter months | 6 |
sars en | 6 |
conventional mr | 6 |
receiver operating | 6 |
initial studies | 6 |
chronic myeloid | 6 |
negative mood | 6 |
intravenous injection | 6 |
control precautions | 6 |
will describe | 6 |
severe cases | 6 |
pathologic findings | 6 |
histologically proven | 6 |
hmpv cases | 6 |
time period | 6 |
nipah virus | 6 |
viral protein | 6 |
blood donations | 6 |
radiographic findings | 6 |
disease threats | 6 |
ru purpose | 6 |
health services | 6 |
sucrose gradient | 6 |
traumatic splenic | 6 |
significant role | 6 |
one hand | 6 |
recombinant proteins | 6 |
brain tissue | 6 |
affinity chromatography | 6 |
adhesion molecule | 6 |
barcelona es | 6 |
many countries | 6 |
intracranial aneurysms | 6 |
valley fever | 6 |
spreading events | 6 |
core biopsies | 6 |
control procedures | 6 |
local recurrence | 6 |
two distinct | 6 |
findings included | 6 |
resonance spectroscopy | 6 |
different regions | 6 |
cc chemokine | 6 |
possible contact | 6 |
resolution us | 6 |
recent reports | 6 |
cognitive decline | 6 |
statistical significance | 6 |
borne diseases | 6 |
locusta migratoria | 6 |
underwent surgery | 6 |
right side | 6 |
transmembrane helix | 6 |
may represent | 6 |
one patients | 6 |
viral validation | 6 |
ultraviolet ray | 6 |
months following | 6 |
three main | 6 |
bulk lipids | 6 |
tracheobronchial tree | 6 |
old man | 6 |
portal phase | 6 |
cho cells | 6 |
nuclear medicine | 6 |
lipid fatty | 6 |
toxic chemicals | 6 |
cell populations | 6 |
based drug | 6 |
several studies | 6 |
dependent rna | 6 |
medical countermeasures | 6 |
higher mean | 6 |
deceased case | 6 |
positive controls | 6 |
study demonstrates | 6 |
enhanced images | 6 |
emerging infections | 6 |
test articles | 6 |
will show | 6 |
knockout mice | 6 |
virus bronchiolitis | 6 |
national institutes | 6 |
tyr residues | 6 |
icu patients | 6 |
genes encoding | 6 |
effective health | 6 |
see section | 6 |
reconstruction phase | 6 |
york city | 6 |
normally myelinated | 6 |
also contribute | 6 |
eight patients | 6 |
structural alignment | 6 |
two rows | 6 |
clinical presentations | 6 |
icu stay | 6 |
uf mra | 6 |
surface coil | 6 |
angiotensin ii | 6 |
clinical specimen | 6 |
bronchogenic cysts | 6 |
cylinder smears | 6 |
noise ratio | 6 |
neurogenic tumors | 6 |
located within | 6 |
will increase | 6 |
secondary antibody | 6 |
viral pathogen | 6 |
outpatient basis | 6 |
prevention programs | 6 |
long bones | 6 |
clinical significance | 6 |
combination therapy | 6 |
antiviral therapy | 6 |
tokyo jp | 6 |
vertebrobasilar insufficiency | 6 |
patient contact | 6 |
wall signal | 6 |
time course | 6 |
elisa tests | 6 |
les voies | 6 |
vertebral development | 6 |
useful information | 6 |
frontal lobe | 6 |